Buscar


Filtros actuales:


Comenzar nueva busqueda

Añadir filtros:

Usa los filtros para afinar la busqueda.


Resultados 1-3 de 3.
  • Anterior
  • 1
  • Siguiente
Resultados por ítem:
Fecha de publicaciónTítuloAutor(es)
2019Analysis of availability and access of anti-myeloma drugs and impact on the management of multiple myeloma in Latin American countries.Navarro Cabrera, Juan Ramón; Pessoa de Magalhães Filho, Roberto José; Crusoe, Edvan; Riva, Eloisa; Bujan, Willen; Conte, Guilhermo; García, Diana Katerine; Quintero Vega, Guilhermo; Macias, José; Oliveros Alvear, Jose Willian; Royg, Mercedes; Andino Neves, Lidiane; Lopez Dopico, Jose Luis; Espino, German; Rosales Ortiz, Douglas; Socarra, Zurelis; Fantl, Dorotea; Ruiz-Arguelles, Guillermo J.; Maiolino, Angelo; Tietsche de Moraes Hungria, Vania; Harousseau, Jean-Luc; Durie, Brian
2018-10PIB: A score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings.Diaz-Ferrer, Javier; Leathers, James S.; Balderramo, Domingo; Prieto, Jhon; Diehl, Fernando; Gonzalez-Ballerga, Esteban; Ferreiro, Melina R.; Carrera, Enrique; Barreyro, Fernando; Singh, Dupinder; Mattos, Angelo Z.; Carrilho, Flair; Debes, José D.
2016-05HannaH phase III randomised study: association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant-adjuvant trastuzumab after 2 years of treatment-free follow-up.Jackisch, Christian; Hegg, Roberto; Stroyakovskiy, Daniil; Jin-Seok Ahn; Melichar, Bohuslav; Shin-Cheh Chen; Sung-Bae Kim; Lichinitser, Mikhail; Starosławska, Elzbieta; Kunz, Georg; Falcón, Silvia; Shou-Tung Chen; Crepelle-Fléchais, Aulde; Heinzmann, Dominik; Shing, Mona; Pivot, Xavier